IP Library Granted Patent US 10,150,975
Granted Patent B2
US 10,150,975 · App. 15/284,727 · Granted Dec 11, 2018

Methods and compositions for producing hydrocarbons

Inventors: Andreas W. Schirmer (South San Francisco, CA); Mathew A. Rude (South San Francisco, CA); Shane A. Brubaker (South San Francisco, CA)
Assignee: REG LIFE SCIENCES, LLC
C12P7/64C10L1/02C12N9/0004C12N9/0008C12N9/88C12P5/02C12P5/026C12P7/04C12P7/24C12P7/649C12P7/6409C12P7/6436C12Y102/0108C12Y401/99005C10L2200/0469C10L2290/26Y02E50/13Y02P20/52Y02T50/678
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,150,975
App. No.
15/284,727
Granted
Dec 11, 2018
Kind
B2
Abstract

Compositions and methods for producing aldehydes, alkanes, and alkenes are described herein. The aldehydes, alkanes, and alkenes can be used in biofuels.

Claims (13)

1. An engineered microorganism for production of an alkane or alkene, comprising an exogenous polynucleotide sequence encoding an alkane or alkene biosynthetic polypeptide, wherein said polynucleotide sequence is operably linked to a promoter, wherein said alkane or alkene biosynthetic polypeptide is selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, and 36.

2. The engineered microorganism of claim 1 , wherein said microorganism is genetically engineered to produce an alkane or an alkene from an aldehyde.

3. The engineered microorganism of claim 2 , wherein said aldehyde is produced by an aldehyde biosynthetic polypeptide that is expressed in the engineered microorganism.

4. The engineered microorganism of claim 3 , wherein said aldehyde biosynthetic polypeptide is an acyl-ACP reductase (AAR) that catalyzes the conversion of an acyl-ACP to a fatty aldehyde.

5. The engineered microorganism of claim 4 , wherein said AAR is selected from the group consisting of SEQ ID NOs: 66, 68, 70, 72, 74, 76, 78, 80, and 82.

6. The engineered microorganism of claim 3 , wherein said aldehyde biosynthetic polypeptide is a carboxylic acid reductase (CAR) that catalyzes the conversion of a fatty acid to a fatty aldehyde.

7. The engineered microorganism of claim 6 , wherein said CAR comprises SEQ ID NO: 86.

8. The engineered microorganism of claim 1 , wherein said alkane or alkene biosynthetic polypeptide catalyzes the conversion of a fatty aldehyde to an alkane or alkene.

9. The engineered microorganism of claim 8 , wherein said engineered microorganism further comprises a thioersterase that catalyzes the conversion of an acyl-ACP to a fatty acid.

10. The engineered microorganism of claim 1 , wherein the microorganism is a bacteria.

11. The engineered microorganism of claim 10 , wherein the bacteria is E. coli.

12. The engineered microorganism of claim 11 , wherein the bacteria is cyanobacteria.

13. A cell culture comprising the engineered microorganism of claim 1 , wherein said alkane or alkene is a C3 to C21 alkane or alkene.

Assignments (2)
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2019
From: REG LIFE SCIENCES, LLC
To: GENOMATICA, INC.
Reel/Frame 050695/0661 →
Continuity (5)
Continuation 14472192 · Aug 28, 2014
Continuation 12710237 · Feb 22, 2010
Continuation In Part PCTUS2009044403 · May 18, 2009
Provisional Application 61053955 · May 16, 2008
Related Publication 20170240927A1 · Aug 24, 2017